Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 9.167E-07 | 3.992E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 3.644E-07 | 3.992E-03 | CA12, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 9.167E-07 | 3.992E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 2.748E-06 | 7.481E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 2.748E-06 | 7.481E-03 | ALOX12, ALOX15 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.901E-07 | 2.696E-05 | CA12; CA7; CA9 |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 2.996E-04 | 6.268E-03 | CASP7; BCL2; MCL1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.419E-04 | 6.268E-03 | CYP1A2; ALOX15 |
hsa05014 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.060E-03 | 1.348E-02 | BCL2; CASP1 |
hsa05134 | Legionellosis_Homo sapiens_hsa05134 | 1.232E-03 | 1.348E-02 | CASP7; CASP1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.563E-03 | 1.348E-02 | ALOX15; ALOX12 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.716E-03 | 1.348E-02 | CYP1A2; ALDH1A1 |
hsa05133 | Pertussis_Homo sapiens_hsa05133 | 2.277E-03 | 1.565E-02 | CASP7; CASP1 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 5.067E-03 | 2.322E-02 | CYP1A2; ALOX15; ALDH1A1; ALOX12; HSD17B10 |
hsa04064 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.474E-03 | 2.123E-02 | LCK; BCL2 |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 4.994E-03 | 2.322E-02 | ALOX15; ALOX12 |
hsa04630 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 9.710E-03 | 4.108E-02 | BCL2; MCL1 |
hsa05010 | Alzheimer's disease_Homo sapiens_hsa05010 | 1.092E-02 | 4.290E-02 | CASP7; HSD17B10 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.741E-03 | 2.322E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Chronic lymphocytic leukaemia | C91 | BCL2 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Advanced melanoma | C43 | BCL2 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | BCL2; BCL2; MCL1; CA9 |
G00-G99: Diseases of the nervous system G00-G99 | Amyotrophic lateral sclerosis | G12.2 | BCL2 |
C00-D49: Neoplasms | Leukemia | C90-C95 | BCL2 |
C00-D49: Neoplasms | Prostate cancer | C61 | BCL2 |
C00-D49: Neoplasms | Breast cancer | C50 | BCL2; CA9 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
C00-D49: Neoplasms | Multiple myeloma | C90 | BCL2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CASP1 |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | BCL2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Autoimmune diabetes | E08-E13 | LCK |
L00-L99: Diseases of the skin and subcutaneous tissue | Fibrosis | L90.5 | CASP1 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; CA9 |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | CASP1 |